One Stop Shop for All Your Market Research Reports

Pharmaceuticals and Healthcare

The World Health Organization states pharmaceuticals represented a US $300 billion-a-year market globally as of 2015. The global pharmaceutical market is expected to surpass the US $400 billion by 2018, with the ten largest pharmaceutical companies altogether commanding about a third of the market. Companies in the pharmaceutical industry are symbolized by their sizeable expenditure on Research and Development and marketing initiatives in a bid to collect more revenue. The development of biopharmaceuticals serves a breakthrough for the industry and personalized therapies carry extremely large promise in the near future. Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and alcove pharmaceutical companies are now waking up to the profitable potential that lies in growth markets.

The healthcare industry deals with the storage, exchange and management of healthcare records between laboratories, insurance agencies, hospitals, patients, and government bodies. The healthcare industry has seen aggressive growth over the last few years. New advances in the information technology domain, connected with the changing demands of patients and healthcare institutions, are combining to shape the future of the global healthcare information technology industry. Many countries are already taking the initiative in implementing extensive Electronic Health Records (EHRs) and as this trend spreads to more countries, several new areas will continue to emerge in the healthcare industry.

Acute Intermittent Porphyria Treatment Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 66
  • Report ID : 1452928
  • Price for Single User : 3250

Acute intermittent porphyriaᅠ(AIP), also calledᅠSwedish porphyria,ᅠpyrroloporphyria,ᅠintermittent acute porphyria) is a rareᅠautosomalᅠdominantᅠmetabolic disorderᅠaffecting the production ofᅠhemeᅠresulting from a deficiency of theᅠporphobilinogen deaminase. It is the most commo [...]

READ MORE

Swedish Porphyria Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 71
  • Report ID : 1452926
  • Price for Single User : 3250

Swedish porphyria is a rareᅠautosomalᅠdominantᅠmetabolic disorderᅠaffecting the production ofᅠhemeᅠresulting from a deficiency of theᅠporphobilinogen deaminase. It is the most common of the acute porphyrias. This report aims to provide a comprehensive presentation of the global market [...]

READ MORE

Acute Intermittent Porphyria Drugs Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 71
  • Report ID : 1452927
  • Price for Single User : 3250

Acute intermittent porphyriaᅠ(AIP), also calledᅠSwedish porphyria,ᅠpyrroloporphyria,ᅠintermittent acute porphyria) is a rareᅠautosomalᅠdominantᅠmetabolic disorderᅠaffecting the production ofᅠhemeᅠresulting from a deficiency of theᅠporphobilinogen deaminase. It is the most commo [...]

READ MORE

Hemin Drugs Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 74
  • Report ID : 1452924
  • Price for Single User : 3250

Hemin is anᅠiron-containingᅠporphyrinᅠwith chlorine that can be formed from aᅠhaemᅠgroup, such asᅠhaem bᅠfound in theᅠhaemoglobinᅠof human blood. This report aims to provide a comprehensive presentation of the global market for Hemin Drugs, with both quantitative and qualitative an [...]

READ MORE

Panhematin Drugs Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 70
  • Report ID : 1452925
  • Price for Single User : 3250

Panhematin is anᅠiron-containingᅠporphyrinᅠwith chlorine that can be formed from aᅠhaemᅠgroup, such asᅠhaem bᅠfound in theᅠhaemoglobinᅠof human blood. This report aims to provide a comprehensive presentation of the global market for Panhematin Drugs, with both quantitative and qual [...]

READ MORE

Panhematin Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 70
  • Report ID : 1452923
  • Price for Single User : 3250

Panhematin is anᅠiron-containingᅠporphyrinᅠwith chlorine that can be formed from aᅠhaemᅠgroup, such asᅠhaem bᅠfound in theᅠhaemoglobinᅠof human blood. This report aims to provide a comprehensive presentation of the global market for Panhematin, with both quantitative and qualitativ [...]

READ MORE

Hemin Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 72
  • Report ID : 1452922
  • Price for Single User : 3250

Hemin is anᅠiron-containingᅠporphyrinᅠwith chlorine that can be formed from aᅠhaemᅠgroup, such asᅠhaem bᅠfound in theᅠhaemoglobinᅠof human blood. This report aims to provide a comprehensive presentation of the global market for Hemin, with both quantitative and qualitative analysis [...]

READ MORE

Acromegaly Drugs Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 78
  • Report ID : 1452921
  • Price for Single User : 3250

Acromegalyᅠis a disorder that results from excess growth hormone (GH) after the growth plates have closed.ᅠIn this report, we study the drugs for Acromegaly. This report aims to provide a comprehensive presentation of the global market for Acromegaly Drugs, with both quantitative and qualitative [...]

READ MORE

Acromegaly Therapeutics Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 63
  • Report ID : 1452920
  • Price for Single User : 3250

Acromegalyᅠis a disorder that results from excess growth hormone (GH) after the growth plates have closed.ᅠIn this report, we study the drugs for Acromegaly. This report aims to provide a comprehensive presentation of the global market for Acromegaly Therapeutics, with both quantitative and qual [...]

READ MORE

Somavert Drugs Market, Global Outlook and Forecast 2023-2029

  • Published by Market Monitor Global
  • On 10-Feb
  • Pages : 71
  • Report ID : 1452919
  • Price for Single User : 3250

Pegvisomant(trade nameᅠSomavert) is aᅠgrowth hormone receptorᅠantagonistᅠused in the treatment ofᅠacromegaly. This report aims to provide a comprehensive presentation of the global market for Somavert Drugs, with both quantitative and qualitative analysis, to help readers develop business/ [...]

READ MORE